來自澳大利亞布裡斯班的皮膚科顧問醫師、脫髮專科醫生、Australasian College of Dermatologists（澳大利亞皮膚科醫師學會）院士Leona Yip博士表示：「臨床接診中，前來治療雄激素性脫髮的青少年與年輕患者越來越多，有些人甚至在十五六歲到十八九歲就出現這種問題。遺傳仍是致病主因，但我們發現，環境與生活方式也會影響遺傳易感人群的脫髮發病時間及發展速度。快速減重、精神壓力、紫外線照射、環境污染、吸煙、代謝異常以及頭皮狀態不佳等因素，都會加劇毛囊周邊的氧化應激與炎症反應。同時，社交媒體提升了大眾認知、健康素養不斷提高，年輕人群能更早發現脫髮跡象，這也為及早干預、長期養護頭皮與毛髮健康創造了有利條件。」
今年五月，該品牌以鉑金贊助商身份亮相在韓國首爾舉辦的第十四屆世界毛髮研究大會。這一大會是毛髮科學領域極具權威性的學術盛會。會上，首爾大學的Jung Won Shin教授與仁荷大學醫院的Kwang Seong Choi教授分享了外用米諾地爾聯合非那雄胺、度他雄胺及低劑量口服米諾地爾等口服藥物治療脫髮的臨床案例。研究結果證實，聯合療法具有改善毛髮再生的潛力。多項臨床案例同時表明，正在服用口服米諾地爾的患者搭配使用外用米諾地爾，可進一步優化治療效果。[7]
[1] Ding Q, Xu YX, Sun WL, Liu JJ, Deng YY, Wu QF, Cao CY, Zhou LB, Lu Y, Fan WX. Early-onset androgenetic alopecia in China: a descriptive study of a large outpatient cohort. J Int Med Res. 2020 Mar;48(3):300060519897190. doi: 10.1177/0300060519897190. PMID: 32188323; PMCID: PMC7105740.
[2] Liu LP, Wariboko MA, Hu X, Wang ZH, Wu Q, Li YM. Factors associated with early-onset androgenetic alopecia: A scoping review. PLoS One. 2024 Mar 7;19(3):e0299212. doi: 10.1371/journal.pone.0299212. PMID: 38451966; PMCID: PMC10919688.
[3] Ho CH, Sood T, Zito PM. Androgenetic Alopecia. [Updated 2024 Jan 7]. In: StatPearls[Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430924/
[4] Nestor MS, Ablon G, Gade A, Han HW, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021 Nov 6;20(12):3759–3781. doi: 10.1111/jocd.14537. PMCID: PMC9298335 PMID: 34741573 https://pmc.ncbi.nlm.nih.gov/articles/PMC9298335/
[5] Hair Loss & Growth Treatments and Products Market. Market Growth Reports. Available from: Market Growth Reports
[6] Li H, Li W, Zhang J, Liang Q, Zhao Y, Guo Z, Jiang B, Wang Z, Qu Q, An S, Miao Y. Risk factors for androgenetic alopecia: a systematic review and meta-analysis. BMC Public Health. 2026 Jan 28;26(1):1000. doi: 10.1186/s12889-026-26258-y. PMID: 41606541; PMCID: PMC13020014.
[7] Kwangsun Choi, Basic therapy for hair loss treatment, the use of topical minoxidil, and case sharing, Proceedings at the World Congress of Hair Research, Seoul, South Korea
來自澳大利亞布裡斯班的皮膚科顧問醫師、脫髮專科醫生、Australasian College of Dermatologists（澳大利亞皮膚科醫師學會）院士Leona Yip博士表示：「臨床接診中，前來治療雄激素性脫髮的青少年與年輕患者越來越多，有些人甚至在十五六歲到十八九歲就出現這種問題。遺傳仍是致病主因，但我們發現，環境與生活方式也會影響遺傳易感人群的脫髮發病時間及發展速度。快速減重、精神壓力、紫外線照射、環境污染、吸煙、代謝異常以及頭皮狀態不佳等因素，都會加劇毛囊周邊的氧化應激與炎症反應。同時，社交媒體提升了大眾認知、健康素養不斷提高，年輕人群能更早發現脫髮跡象，這也為及早干預、長期養護頭皮與毛髮健康創造了有利條件。」
今年五月，該品牌以鉑金贊助商身份亮相在韓國首爾舉辦的第十四屆世界毛髮研究大會。這一大會是毛髮科學領域極具權威性的學術盛會。會上，首爾大學的Jung Won Shin教授與仁荷大學醫院的Kwang Seong Choi教授分享了外用米諾地爾聯合非那雄胺、度他雄胺及低劑量口服米諾地爾等口服藥物治療脫髮的臨床案例。研究結果證實，聯合療法具有改善毛髮再生的潛力。多項臨床案例同時表明，正在服用口服米諾地爾的患者搭配使用外用米諾地爾，可進一步優化治療效果。[7]
[1] Ding Q, Xu YX, Sun WL, Liu JJ, Deng YY, Wu QF, Cao CY, Zhou LB, Lu Y, Fan WX. Early-onset androgenetic alopecia in China: a descriptive study of a large outpatient cohort. J Int Med Res. 2020 Mar;48(3):300060519897190. doi: 10.1177/0300060519897190. PMID: 32188323; PMCID: PMC7105740.
[2] Liu LP, Wariboko MA, Hu X, Wang ZH, Wu Q, Li YM. Factors associated with early-onset androgenetic alopecia: A scoping review. PLoS One. 2024 Mar 7;19(3):e0299212. doi: 10.1371/journal.pone.0299212. PMID: 38451966; PMCID: PMC10919688.
[3] Ho CH, Sood T, Zito PM. Androgenetic Alopecia. [Updated 2024 Jan 7]. In: StatPearls[Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430924/
[4] Nestor MS, Ablon G, Gade A, Han HW, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021 Nov 6;20(12):3759–3781. doi: 10.1111/jocd.14537. PMCID: PMC9298335 PMID: 34741573 https://pmc.ncbi.nlm.nih.gov/articles/PMC9298335/
[5] Hair Loss & Growth Treatments and Products Market. Market Growth Reports. Available from: Market Growth Reports
[6] Li H, Li W, Zhang J, Liang Q, Zhao Y, Guo Z, Jiang B, Wang Z, Qu Q, An S, Miao Y. Risk factors for androgenetic alopecia: a systematic review and meta-analysis. BMC Public Health. 2026 Jan 28;26(1):1000. doi: 10.1186/s12889-026-26258-y. PMID: 41606541; PMCID: PMC13020014.
[7] Kwangsun Choi, Basic therapy for hair loss treatment, the use of topical minoxidil, and case sharing, Proceedings at the World Congress of Hair Research, Seoul, South Korea
來自澳大利亞布裡斯班的皮膚科顧問醫師、脫髮專科醫生、Australasian College of Dermatologists（澳大利亞皮膚科醫師學會）院士Leona Yip博士表示：「臨床接診中，前來治療雄激素性脫髮的青少年與年輕患者越來越多，有些人甚至在十五六歲到十八九歲就出現這種問題。遺傳仍是致病主因，但我們發現，環境與生活方式也會影響遺傳易感人群的脫髮發病時間及發展速度。快速減重、精神壓力、紫外線照射、環境污染、吸煙、代謝異常以及頭皮狀態不佳等因素，都會加劇毛囊周邊的氧化應激與炎症反應。同時，社交媒體提升了大眾認知、健康素養不斷提高，年輕人群能更早發現脫髮跡象，這也為及早干預、長期養護頭皮與毛髮健康創造了有利條件。」
今年五月，該品牌以鉑金贊助商身份亮相在韓國首爾舉辦的第十四屆世界毛髮研究大會。這一大會是毛髮科學領域極具權威性的學術盛會。會上，首爾大學的Jung Won Shin教授與仁荷大學醫院的Kwang Seong Choi教授分享了外用米諾地爾聯合非那雄胺、度他雄胺及低劑量口服米諾地爾等口服藥物治療脫髮的臨床案例。研究結果證實，聯合療法具有改善毛髮再生的潛力。多項臨床案例同時表明，正在服用口服米諾地爾的患者搭配使用外用米諾地爾，可進一步優化治療效果。[7]
[1] Ding Q, Xu YX, Sun WL, Liu JJ, Deng YY, Wu QF, Cao CY, Zhou LB, Lu Y, Fan WX. Early-onset androgenetic alopecia in China: a descriptive study of a large outpatient cohort. J Int Med Res. 2020 Mar;48(3):300060519897190. doi: 10.1177/0300060519897190. PMID: 32188323; PMCID: PMC7105740.
[2] Liu LP, Wariboko MA, Hu X, Wang ZH, Wu Q, Li YM. Factors associated with early-onset androgenetic alopecia: A scoping review. PLoS One. 2024 Mar 7;19(3):e0299212. doi: 10.1371/journal.pone.0299212. PMID: 38451966; PMCID: PMC10919688.
[3] Ho CH, Sood T, Zito PM. Androgenetic Alopecia. [Updated 2024 Jan 7]. In: StatPearls[Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430924/
[4] Nestor MS, Ablon G, Gade A, Han HW, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021 Nov 6;20(12):3759–3781. doi: 10.1111/jocd.14537. PMCID: PMC9298335 PMID: 34741573 https://pmc.ncbi.nlm.nih.gov/articles/PMC9298335/
[5] Hair Loss & Growth Treatments and Products Market. Market Growth Reports. Available from: Market Growth Reports
[6] Li H, Li W, Zhang J, Liang Q, Zhao Y, Guo Z, Jiang B, Wang Z, Qu Q, An S, Miao Y. Risk factors for androgenetic alopecia: a systematic review and meta-analysis. BMC Public Health. 2026 Jan 28;26(1):1000. doi: 10.1186/s12889-026-26258-y. PMID: 41606541; PMCID: PMC13020014.
[7] Kwangsun Choi, Basic therapy for hair loss treatment, the use of topical minoxidil, and case sharing, Proceedings at the World Congress of Hair Research, Seoul, South Korea
來自澳大利亞布裡斯班的皮膚科顧問醫師、脫髮專科醫生、Australasian College of Dermatologists（澳大利亞皮膚科醫師學會）院士Leona Yip博士表示：「臨床接診中，前來治療雄激素性脫髮的青少年與年輕患者越來越多，有些人甚至在十五六歲到十八九歲就出現這種問題。遺傳仍是致病主因，但我們發現，環境與生活方式也會影響遺傳易感人群的脫髮發病時間及發展速度。快速減重、精神壓力、紫外線照射、環境污染、吸煙、代謝異常以及頭皮狀態不佳等因素，都會加劇毛囊周邊的氧化應激與炎症反應。同時，社交媒體提升了大眾認知、健康素養不斷提高，年輕人群能更早發現脫髮跡象，這也為及早干預、長期養護頭皮與毛髮健康創造了有利條件。」
今年五月，該品牌以鉑金贊助商身份亮相在韓國首爾舉辦的第十四屆世界毛髮研究大會。這一大會是毛髮科學領域極具權威性的學術盛會。會上，首爾大學的Jung Won Shin教授與仁荷大學醫院的Kwang Seong Choi教授分享了外用米諾地爾聯合非那雄胺、度他雄胺及低劑量口服米諾地爾等口服藥物治療脫髮的臨床案例。研究結果證實，聯合療法具有改善毛髮再生的潛力。多項臨床案例同時表明，正在服用口服米諾地爾的患者搭配使用外用米諾地爾，可進一步優化治療效果。[7]
[1] Ding Q, Xu YX, Sun WL, Liu JJ, Deng YY, Wu QF, Cao CY, Zhou LB, Lu Y, Fan WX. Early-onset androgenetic alopecia in China: a descriptive study of a large outpatient cohort. J Int Med Res. 2020 Mar;48(3):300060519897190. doi: 10.1177/0300060519897190. PMID: 32188323; PMCID: PMC7105740.
[2] Liu LP, Wariboko MA, Hu X, Wang ZH, Wu Q, Li YM. Factors associated with early-onset androgenetic alopecia: A scoping review. PLoS One. 2024 Mar 7;19(3):e0299212. doi: 10.1371/journal.pone.0299212. PMID: 38451966; PMCID: PMC10919688.
[3] Ho CH, Sood T, Zito PM. Androgenetic Alopecia. [Updated 2024 Jan 7]. In: StatPearls[Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430924/
[4] Nestor MS, Ablon G, Gade A, Han HW, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021 Nov 6;20(12):3759–3781. doi: 10.1111/jocd.14537. PMCID: PMC9298335 PMID: 34741573 https://pmc.ncbi.nlm.nih.gov/articles/PMC9298335/
[5] Hair Loss & Growth Treatments and Products Market. Market Growth Reports. Available from: Market Growth Reports
[6] Li H, Li W, Zhang J, Liang Q, Zhao Y, Guo Z, Jiang B, Wang Z, Qu Q, An S, Miao Y. Risk factors for androgenetic alopecia: a systematic review and meta-analysis. BMC Public Health. 2026 Jan 28;26(1):1000. doi: 10.1186/s12889-026-26258-y. PMID: 41606541; PMCID: PMC13020014.
[7] Kwangsun Choi, Basic therapy for hair loss treatment, the use of topical minoxidil, and case sharing, Proceedings at the World Congress of Hair Research, Seoul, South Korea
